spacer
home > ict > summer 2018 > navigating global complexities
PUBLICATIONS
International Clinical Trials

Navigating Global Complexities

Insurance is a small part of the global clinical trial process, but it can have a huge impact on the contract or clinical research company’s efforts geared towards ensuring trials proceed smoothly.

Making sure a clinical trial’s insurance policy stands up to the scrutiny of the ethics committee in each territory is essential. Inappropriate insurance documentation presented to the ethics committee meeting could delay the onset of the trial until at least their next meeting, reducing the patent exclusivity period, potentially costing millions of pounds and negatively affecting important business relationships.

Having a sound understanding of the legislation and regulations governing clinical trials in the territory where the company is testing is the best starting point.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Kathryn Moon is ACII qualified and has worked in the insurance industry for over 20 years in a variety of roles including Account Broker, Project Manager, Development Manager, and Account Executive. She is currently Managing Director of the Coventry office of Gallagher – the global insurance broker, risk management services, and consulting firm – and an integral part of its UK life sciences specialism. Gallagher are also members of OBN.
spacer
Kathryn Moon
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo awarded with the prestigious Cargo Airline of the Year 2019 prize by the global logistics industry

 Maintaining its upward trend, Turkish Cargo was granted with the ‘Cargo Airline of the Year 2019’ award, called as the Oscar of the global logistics industry, by the global air cargo sector readers of the Air Cargo News magazine.
More info >>

White Papers

Maximize the ROI of Your Post-Approval Research

Bioclinica

Expenditures in post-approval (Phase IV) research are going up across the pharmaceutical, biotech and medical device industries. Given the resources you’ve committed to post-approval research, you may be wondering if you’re getting the greatest possible return on your investment. Discover how to harness the power of post-approval research to increase data collection, reduce resource burn, save money, and maximize your ROI!
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement